Unmet need among over 7000 rare diseases is being addressed in a comprehensive action plan More: Neglected rare disease patients offered hope in new plan Source: News
read moreJudge backs Johnson & Johnson in bankruptcy ploy for talc litigation, clears way for settlement kdunleavy Fri, 02/25/2022 – 16:07 More: Judge backs Johnson & Johnson in bankruptcy ploy for talc litigation, clears way for settlement Source: fierce
read moreEMA expands nods for BMS, Eli Lilly, Novartis drugs and backs Biohaven, VBI, Myovant therapies for first time aliu Fri, 02/25/2022 – 11:36 More: EMA expands nods for BMS, Eli Lilly, Novartis drugs and backs Biohaven, VBI, Myovant therapies for
read moreEmergent underway with $100M in manufacturing upgrades as it gears up for ‘post-pandemic work’ kdunleavy Fri, 02/25/2022 – 10:15 More: Emergent underway with 0M in manufacturing upgrades as it gears up for 'post-pandemic work' Source: fierce
read moreJohnson & Johnson, distributor giants finalize $26B opioid settlement as states pile into landmark deal aliu Fri, 02/25/2022 – 09:45 More: Johnson & Johnson, distributor giants finalize B opioid settlement as states pile into landmark deal Source: fierce
read moreValneva expects to receive a positive CHMP recommendation for the conditional approval of its VLA2001 vaccine More: CHMP provides initial assessment of Valneva’s COVID-19 vaccine Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals